LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 16

Search options

  1. Article ; Online: Estimating postoperative mortality in colorectal surgery- a systematic review of risk prediction models.

    Dosis, Alexios / Helliwell, Jack / Syversen, Aron / Tiernan, Jim / Zhang, Zhiqiang / Jayne, David

    International journal of colorectal disease

    2023  Volume 38, Issue 1, Page(s) 155

    Abstract: Purpose: Risk prediction models are frequently used to support decision-making in colorectal surgery but can be inaccurate. Machine learning (ML) is becoming increasingly popular, and its application may increase predictive accuracy. We compared ... ...

    Abstract Purpose: Risk prediction models are frequently used to support decision-making in colorectal surgery but can be inaccurate. Machine learning (ML) is becoming increasingly popular, and its application may increase predictive accuracy. We compared conventional risk prediction models for postoperative mortality (based on regression analysis) with ML models to determine the benefit of the latter approach.
    Methods: The study was registered in PROSPERO(CRD42022364753). Following the PRISMA guidelines, a systematic search of three databases (MEDLINE, EMBASE, WoS) was conducted (from 1/1/2000 to 29/09/2022). Studies were included if they reported the development of a risk model to estimate short-term postoperative mortality for patients undergoing colorectal surgery. Discrimination and calibration performance metrics were compared. Studies were evaluated against CHARMS and TRIPOD criteria.
    Results: 3,052 articles were screened, and 45 studies were included. The total sample size was 1,356,058 patients. Six studies used ML techniques for model development. Most studies (n = 42) reported the area under the receiver operating characteristic curve (AUROC) as a measure of discrimination. There was no significant difference in the mean AUROC values between regression models (0.833 s.d. ± 0.52) and ML (0.846 s.d. ± 0.55), p = 0.539. Calibration statistics, which measure the agreement between predicted estimates and observed outcomes, were less consistent. Risk of bias assessment found most concerns in the data handling and analysis domains of eligible studies.
    Conclusions: Our study showed comparable predictive performance between regression and ML methods in colorectal surgery. Integration of ML in colorectal risk prediction is promising but further refinement of the models is required to support routine clinical adoption.
    MeSH term(s) Humans ; Colorectal Surgery/adverse effects ; Digestive System Surgical Procedures ; Area Under Curve ; Calibration ; Databases, Factual
    Language English
    Publishing date 2023-06-01
    Publishing country Germany
    Document type Systematic Review ; Journal Article ; Review
    ZDB-ID 84975-3
    ISSN 1432-1262 ; 0179-1958
    ISSN (online) 1432-1262
    ISSN 0179-1958
    DOI 10.1007/s00384-023-04455-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Duplication and nonregistration of COVID-19 systematic reviews: Bibliometric review.

    Helliwell, Jack A / Thompson, Joe / Smart, Neil / Jayne, David G / Chapman, Stephen J

    Health science reports

    2022  Volume 5, Issue 3, Page(s) e541

    Abstract: Objectives: This study examines the conduct of systematic reviews during the early stages of the COVID-19 pandemic, including compliance to protocol registration and duplication of reviews on similar topics. The methodological and reporting quality were ...

    Abstract Objectives: This study examines the conduct of systematic reviews during the early stages of the COVID-19 pandemic, including compliance to protocol registration and duplication of reviews on similar topics. The methodological and reporting quality were also explored.
    Methods: A cross-sectional, bibliometric study was undertaken of all systematic review manuscripts on a COVID-19 intervention published between January 1st and June 30th, 2020. Protocol registration on a publicly accessible database was recorded. Duplication was determined by systematically recording the number of reviews published on each topic of analysis. Methodological quality and reporting quality were assessed using the AMSTAR-2 and PRISMA 2009 instruments, respectively.
    Results: Thirty-one eligible systematic reviews were identified during the inclusion period. The protocol of only four (12.9%) studies was registered on a publicly accessible database. Duplication was frequent, with 15 (48.4%) of the 31 included studies focusing on either hydroxychloroquine (and/or chloroquine) or corticosteroids. Only one study (3.2%) was of "high" methodological quality, four (12.9%) were "low" quality, and the remainder (
    Conclusion: Systematic reviews during the early stages of the COVID-19 pandemic were uncommonly registered, frequently duplicated, and mostly of low methodological quality. In contrast, the reporting quality of manuscripts was generally good but varied substantially across published reports. There is a need for heightened stewardship of systematic review research, particularly during times of medical crisis where the generation of primary evidence may be rapid and unstable.
    Language English
    Publishing date 2022-04-21
    Publishing country United States
    Document type Journal Article
    ISSN 2398-8835
    ISSN (online) 2398-8835
    DOI 10.1002/hsr2.541
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Noninvasive vagus nerve stimulation to reduce ileus after major colorectal surgery: early development study.

    Chapman, Stephen J / Helliwell, Jack A / Naylor, Maureen / Tassinari, Cerys / Corrigan, Neil / Jayne, David G

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

    2021  Volume 23, Issue 5, Page(s) 1225–1232

    Abstract: Aim: Vagus nerve stimulation has emerged as a plausible intervention to reduce ileus after surgery. An early development study was undertaken with the aim of exploring the feasibility of self-administered, noninvasive vagus nerve stimulation (nVNS) ... ...

    Abstract Aim: Vagus nerve stimulation has emerged as a plausible intervention to reduce ileus after surgery. An early development study was undertaken with the aim of exploring the feasibility of self-administered, noninvasive vagus nerve stimulation (nVNS) after major colorectal surgery.
    Method: A parallel-group, randomized controlled trial was undertaken between 1 January 2018 and 31 August 2019. Forty patients undergoing colorectal surgery for malignancy were allocated equally to Sham and Active stimulation groups. Electrical vagus nerve stimulation was self-administered bilaterally over the cervical surface landmarks for 5 days before and after surgery. Outcomes of interest were postoperative complications and adverse events measured using the Clavien-Dindo scale, treatment compliance, device usability according to the Systems Usability Scale (SUS) and clinical measures of bowel recovery.
    Results: Forty patients were randomized and one withdrew, leaving 39 for analysis. Postoperative complications occurred in 9/19 (47.4%) participants receiving Sham and 11/20 (55.0%) receiving Active stimulation and were mostly minor. Compliance with treatment before surgery was 4.7 ± 0.9 days out of 5 days in the Sham group and 4.7 ± 1.1 in the Active group. Compliance with treatment after surgery was 4.1 ± 1.1 and 4.4 ± 1.5, respectively. Participants considered the intervention to be 'acceptable' according to the SUS. The most prominent differences in bowel recovery were days to first flatus (2.35 ± 1.32 vs 1.65 ± 0.88) and tolerance of solid diet (2.18 ± 2.21 vs 1.75 ± 0.91) for Sham and Active groups, respectively.
    Conclusion: This study supports the safety, treatment compliance and usability of self-administered nVNS in patients undergoing major colorectal surgery.
    MeSH term(s) Colorectal Surgery ; Digestive System Surgical Procedures ; Humans ; Ileus/etiology ; Ileus/prevention & control ; Treatment Outcome ; Vagus Nerve Stimulation/adverse effects
    Language English
    Publishing date 2021-02-21
    Publishing country England
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 1440017-0
    ISSN 1463-1318 ; 1462-8910
    ISSN (online) 1463-1318
    ISSN 1462-8910
    DOI 10.1111/codi.15561
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The use of mesenchymal stem cells in animal models for gastrointestinal anastomotic leak: A systematic review.

    Burke, Joshua Richard / Helliwell, Jack / Wong, Jason / Quyn, Aaron / Herrick, Sarah / Jayne, David

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

    2021  Volume 23, Issue 12, Page(s) 3123–3140

    Abstract: Aim: Anastomotic leak is the most feared complication of gastrointestinal surgery. Mesenchymal stem cell technology is used clinically to promote wound healing; however, the safety and efficacy of this technology on anastomotic healing has yet to be ... ...

    Abstract Aim: Anastomotic leak is the most feared complication of gastrointestinal surgery. Mesenchymal stem cell technology is used clinically to promote wound healing; however, the safety and efficacy of this technology on anastomotic healing has yet to be defined. The aim of this study was to investigate whether mesenchymal stem cells confer any benefit when applied to animal models for gastrointestinal anastomotic leak, identify the methodology and how efficacy is assessed.
    Methods: The MEDLINE, EMBASE, WebofScience and Cochrane Library databases were interrogated between 1 January1947 to 1 May 2020. All studies where mesenchymal stem cells were applied to laboratory animal leak models to demonstrate a healing effect were considered. All experimental and histological outcomes were examined. Compliance to ARRIVE and current International Consensus was assessed.
    Results: A total of 1205 studies were screened. Twelve studies reported on 438 gastrointestinal anastomoses in four species using 11 models; seven in the colon. No studies utilised a model with a known leak rate. Significant variance was observed in histological outcomes with efficacy demonstrated in five out of 12 studies. One study demonstrated a benefit in leak rate. Colorectal studies had a greater median ARRIVE compliance, 60.8% (IQR 63.2-64.5) compared to noncolorectal 45.4% (IQR 43.8-49.0).
    Conclusions: Mesenchymal stem cell delivery to an animal anastomosis is safe and feasible. Use may confer benefit but findings are currently limited to surrogate histological outcomes. There is consistency in outcome measures reported but variance in how this is assessed. Poor compliance to ARRIVE but good compliance to current international consensus in leak models of the colon was observed.
    MeSH term(s) Anastomosis, Surgical/adverse effects ; Anastomotic Leak/etiology ; Animals ; Colon/surgery ; Disease Models, Animal ; Mesenchymal Stem Cells
    Language English
    Publishing date 2021-08-20
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review ; Systematic Review
    ZDB-ID 1440017-0
    ISSN 1463-1318 ; 1462-8910
    ISSN (online) 1463-1318
    ISSN 1462-8910
    DOI 10.1111/codi.15864
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Rapid qualitative analysis in a mixed-methods evaluation of an infection prevention intervention in a UK hospital setting during the COVID-19 pandemic: A discussion of the CLEAN study methodology.

    Higham, Ruchi / Pini, Simon / Quyn, Aaron / Kowal, Mikolaj / Helliwell, Jack / Saman, Razan / Lewthwaite, Penny / Young, Nicola / Rousseau, Nikki

    Frontiers in sociology

    2022  Volume 7, Page(s) 958250

    Abstract: The COVID-19 pandemic created an urgent need for high-quality rapid research. One clinical challenge was how to minimise the risk of transmission in the hospital setting. The CLEAN study conducted a rapid evaluation of the potential utility of a spray- ... ...

    Abstract The COVID-19 pandemic created an urgent need for high-quality rapid research. One clinical challenge was how to minimise the risk of transmission in the hospital setting. The CLEAN study conducted a rapid evaluation of the potential utility of a spray-based disinfectant in a hospital setting. The study was undertaken between December 2020 and March 2021 and involved the implementation of the spray in 10 different clinical areas in one UK teaching hospital. A mixed-methods approach was adopted (including observations, surveys, and qualitative interviews) informed by the theories for understanding the implementation of new healthcare technologies. The evaluation found that while the spray had a number of perceived benefits when added to existing disinfection processes, other factors limited its potential utility. These findings informed a number of recommendations for future adoption within hospital settings. This paper describes and reflects on the rapid methodology that allowed us to undertake the study and deliver results in a short space of time. We experienced a number of pressures during set-up and fieldwork due to the challenging conditions caused by the pandemic, and the methodological approach had to evolve throughout the study because of the changing clinical context. The involvement of clinicians from the research setting as full members of the research team was key to the rapid delivery of the research. They provided an essential link to the implementation environment, and their experiential knowledge of the setting added an important perspective to the analysis. Balancing their involvement with their clinical roles was challenging, however, as was coordinating a large and diverse team of interviewers in such a short space of time. Overall, the study highlighted the value of rapid research to inform urgent healthcare decisions in a pandemic. Although our experience suggests that conducting such research requires some practical and methodological trade-offs, we found that there were also numerous benefits of using rapid methods and identified various opportunities to ensure their robustness.
    Language English
    Publishing date 2022-10-25
    Publishing country Switzerland
    Document type Journal Article
    ISSN 2297-7775
    ISSN (online) 2297-7775
    DOI 10.3389/fsoc.2022.958250
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Global academic response to COVID-19: Cross-sectional study.

    Helliwell, Jack A / Bolton, William S / Burke, Joshua R / Tiernan, Jim P / Jayne, David G / Chapman, Stephen J

    Learned publishing : journal of the Association of Learned and Professional Society Publishers

    2020  Volume 33, Issue 4, Page(s) 385–393

    Abstract: This study explores the response to COVID-19 from investigators, editors, and publishers and seeks to define challenges during the early stages of the pandemic. A cross-sectional bibliometric review of COVID-19 literature was undertaken between 1 ... ...

    Abstract This study explores the response to COVID-19 from investigators, editors, and publishers and seeks to define challenges during the early stages of the pandemic. A cross-sectional bibliometric review of COVID-19 literature was undertaken between 1 November 2019 and 24 March 2020, along with a comparative review of Middle East respiratory syndrome (MERS) literature. Investigator responsiveness was assessed by measuring the volume and type of research published. Editorial responsiveness was assessed by measuring the submission-to-acceptance time and availability of original data. Publisher-responsiveness was assessed by measuring the acceptance-to-publication time and the provision of open access. Three hundred and ninety-eight of 2,835 COVID-19 and 55 of 1,513 MERS search results were eligible. Most COVID-19 studies were clinical reports (
    Key points: COVID-19 publications show rapid response from investigators, specifically aiming to define the disease.Median time between submission and acceptance of COVID-19 articles is 5 days demonstrating rapid decision-making compared with the median of 71.5 days for MERS articles.Median time from acceptance to publication of COVID-19 articles is 5 days, confirming the ability to introduce rapid increases at times of crisis, such as during the SARS outbreak.The majority of both COVID-19 and MERS articles are available open-access.
    Keywords covid19
    Language English
    Publishing date 2020-07-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 2018596-0
    ISSN 1741-4857 ; 0953-1513
    ISSN (online) 1741-4857
    ISSN 0953-1513
    DOI 10.1002/leap.1317
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Global academic response to COVID ‐19

    Helliwell, Jack A. / Bolton, William S. / Burke, Joshua R. / Tiernan, Jim P. / Jayne, David G. / Chapman, Stephen J.

    Learned Publishing

    Cross‐sectional study

    2020  Volume 33, Issue 4, Page(s) 385–393

    Keywords Communication ; covid19
    Language English
    Publisher Wiley
    Publishing country us
    Document type Article ; Online
    ISSN 0953-1513
    DOI 10.1002/leap.1317
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Long-term Outcomes following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) versus Pancreatic Ductal Adenocarcinoma (PDAC): A Propensity-score Matched Analysis.

    Lucocq, James / Halle-Smith, James / Haugk, Beate / Joseph, Nejo / Hawkyard, Jake / Lye, Jonathan / Parkinson, Daniel / White, Steve / Mownah, Omar / Zen, Yoh / Menon, Krishna / Furukawa, Takaki / Inoue, Yosuke / Hirose, Yuki / Sasahira, Naoki / Mittal, Anubhav / Samra, Jas / Sheen, Amy / Feretis, Michael /
    Balakrishnan, Anita / Ceresa, Carlo / Davidson, Brian / Pande, Rupaly / Dasari, Bobby V M / Tanno, Lulu / Karavias, Dimitrios / Helliwell, Jack / Young, Alistair / Marks, Kate / Nunes, Quentin / Urbonas, Tomas / Silva, Michael / Gordon-Weeks, Alex / Barrie, Jenifer / Gomez, Dhanny / van Laarhoven, Stijn / Nawara, Hossam / Doyle, Joseph / Bhogal, Ricky / Harrison, Ewen / Roalso, Marcus / Ciprani, Debora / Aroori, Somaiah / Ratnayake, Bathiya / Koea, Jonathan / Capurso, Gabriele / Bellotti, Ruben / Stättner, Stefan / Alsaoudi, Tareq / Bhardwaj, Neil / Rajesh, Srujan / Jeffery, Fraser / Connor, Saxon / Cameron, Andrew / Jamieson, Nigel / Soreide, Kjetil / Gill, Anthony J / Roberts, Keith / Pandanaboyana, Sanjay

    Annals of surgery

    2024  

    Abstract: Objective: The aim of the present study was to compare long-term post-resection oncological outcomes between A-IPMN and PDAC.: Summary background data: Knowledge of long term oncological outcomes (e.g recurrence and survival data) comparing between ... ...

    Abstract Objective: The aim of the present study was to compare long-term post-resection oncological outcomes between A-IPMN and PDAC.
    Summary background data: Knowledge of long term oncological outcomes (e.g recurrence and survival data) comparing between adenocarcinoma arising from intraductal papillary mucinous neoplasms (A-IPMN) and pancreatic ductal adenocarcinoma (PDAC) is scarce.
    Methods: Patients undergoing pancreatic resection (2010-2020) for A-IPMN were identified retrospectively from 18 academic pancreatic centres and compared with PDAC patients from the same time-period. Propensity-score matching (PSM) was performed and survival and recurrence were compared between A-IPMN and PDAC.
    Results: 459 A-IPMN patients (median age,70; M:F,250:209) were compared with 476 PDAC patients (median age,69; M:F,262:214). A-IPMN patients had lower T-stage, lymphovascular invasion (51.4%vs. 75.6%), perineural invasion (55.8%vs. 71.2%), lymph node positivity (47.3vs. 72.3%) and R1 resection (38.6%vs. 56.3%) compared to PDAC(P<0.001). The median survival and time-to-recurrence for A-IPMN versus PDAC were 39.0 versus19.5months (P<0.001) and 33.1 versus 14.8months (P<0.001), respectively (median follow-up,78 vs.73 months). Ten-year overall survival for A-IPMN was 34.6%(27/78) and PDAC was 9%(6/67). A-IPMN had higher rates of peritoneal (23.0 vs. 9.1%, P<0.001) and lung recurrence (27.8% vs. 15.6%, P<0.001) but lower rates of locoregional recurrence (39.7% vs. 57.8%; P<0.001). Matched analysis demonstrated inferior overall survival (P=0.005), inferior disease-free survival (P=0.003) and higher locoregional recurrence (P<0.001) in PDAC compared to A-IPMN but no significant difference in systemic recurrence rates (P=0.695).
    Conclusions: PDACs have inferior survival and higher recurrence rates compared to A-IPMN in matched cohorts. Locoregional recurrence is higher in PDAC but systemic recurrence rates are comparable and constituted by their own distinctive site-specific recurrence patterns.
    Language English
    Publishing date 2024-03-22
    Publishing country United States
    Document type Journal Article
    ZDB-ID 340-2
    ISSN 1528-1140 ; 0003-4932
    ISSN (online) 1528-1140
    ISSN 0003-4932
    DOI 10.1097/SLA.0000000000006272
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN study.

    Lucocq, James / Hawkyard, Jake / Haugk, Beate / Mownah, Omar / Menon, Krishna / Furukawa, Takaki / Inoue, Yosuke / Hirose, Yuki / Sasahira, Naoki / Feretis, Michael / Balakrishnan, Anita / Ceresa, Carlo / Davidson, Brian / Pande, Rupaly / Dasari, Bobby / Tanno, Lulu / Karavias, Dimitrios / Helliwell, Jack / Young, Alistair /
    Nunes, Quentin / Urbonas, Tomas / Silva, Michael / Gordon-Weeks, Alex / Barrie, Jenifer / Gomez, Dhanny / Van Laarhoven, Stijn / Robertson, Francis / Nawara, Hossain / Doyle, Joseph / Bhogal, Ricky / Harrison, Ewen / Roalso, Marcus / Ciprani, Debora / Aroori, Somaiah / Ratnayake, Bathiya / Koea, Jonathan / Capurso, Gabriele / Bellotti, Ruben / Stättner, Stefan / Alsaoudi, Tareq / Bhardwaj, Neil / Rajesh, Srujan / Jeffery, Fraser / Connor, Saxon / Cameron, Andrew / Jamieson, Nigel / Sheen, Amy / Mittal, Anubhav / Samra, Jas / Gill, Anthony / Roberts, Keith / Søreide, Kjetil / Pandanaboyana, Sanjay

    The British journal of surgery

    2024  Volume 111, Issue 4

    Abstract: Background: The clinical impact of adjuvant chemotherapy after resection for adenocarcinoma arising from intraductal papillary mucinous neoplasia is unclear. The aim of this study was to identify factors related to receipt of adjuvant chemotherapy and ... ...

    Abstract Background: The clinical impact of adjuvant chemotherapy after resection for adenocarcinoma arising from intraductal papillary mucinous neoplasia is unclear. The aim of this study was to identify factors related to receipt of adjuvant chemotherapy and its impact on recurrence and survival.
    Methods: This was a multicentre retrospective study of patients undergoing pancreatic resection for adenocarcinoma arising from intraductal papillary mucinous neoplasia between January 2010 and December 2020 at 18 centres. Recurrence and survival outcomes for patients who did and did not receive adjuvant chemotherapy were compared using propensity score matching.
    Results: Of 459 patients who underwent pancreatic resection, 275 (59.9%) received adjuvant chemotherapy (gemcitabine 51.3%, gemcitabine-capecitabine 21.8%, FOLFIRINOX 8.0%, other 18.9%). Median follow-up was 78 months. The overall recurrence rate was 45.5% and the median time to recurrence was 33 months. In univariable analysis in the matched cohort, adjuvant chemotherapy was not associated with reduced overall (P = 0.713), locoregional (P = 0.283) or systemic (P = 0.592) recurrence, disease-free survival (P = 0.284) or overall survival (P = 0.455). Adjuvant chemotherapy was not associated with reduced site-specific recurrence. In multivariable analysis, there was no association between adjuvant chemotherapy and overall recurrence (HR 0.89, 95% c.i. 0.57 to 1.40), disease-free survival (HR 0.86, 0.59 to 1.30) or overall survival (HR 0.77, 0.50 to 1.20). Adjuvant chemotherapy was not associated with reduced recurrence in any high-risk subgroup (for example, lymph node-positive, higher AJCC stage, poor differentiation). No particular chemotherapy regimen resulted in superior outcomes.
    Conclusion: Chemotherapy following resection of adenocarcinoma arising from intraductal papillary mucinous neoplasia does not appear to influence recurrence rates, recurrence patterns or survival.
    MeSH term(s) Aged ; Female ; Humans ; Male ; Middle Aged ; Adenocarcinoma/pathology ; Adenocarcinoma/drug therapy ; Adenocarcinoma/mortality ; Adenocarcinoma/therapy ; Adenocarcinoma, Mucinous/pathology ; Adenocarcinoma, Mucinous/drug therapy ; Adenocarcinoma, Mucinous/therapy ; Adenocarcinoma, Mucinous/mortality ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Capecitabine/administration & dosage ; Capecitabine/therapeutic use ; Carcinoma, Pancreatic Ductal/pathology ; Carcinoma, Pancreatic Ductal/mortality ; Carcinoma, Pancreatic Ductal/drug therapy ; Carcinoma, Pancreatic Ductal/therapy ; Carcinoma, Pancreatic Ductal/surgery ; Chemotherapy, Adjuvant ; Gemcitabine ; Neoplasm Recurrence, Local/epidemiology ; Pancreatectomy ; Pancreatic Intraductal Neoplasms/pathology ; Pancreatic Intraductal Neoplasms/therapy ; Pancreatic Intraductal Neoplasms/mortality ; Pancreatic Intraductal Neoplasms/surgery ; Pancreatic Neoplasms/pathology ; Pancreatic Neoplasms/drug therapy ; Pancreatic Neoplasms/mortality ; Pancreatic Neoplasms/therapy ; Pancreatic Neoplasms/surgery ; Propensity Score ; Retrospective Studies
    Chemical Substances Capecitabine (6804DJ8Z9U) ; Gemcitabine
    Language English
    Publishing date 2024-04-24
    Publishing country England
    Document type Journal Article ; Multicenter Study
    ZDB-ID 2985-3
    ISSN 1365-2168 ; 0263-1202 ; 0007-1323 ; 1355-7688
    ISSN (online) 1365-2168
    ISSN 0263-1202 ; 0007-1323 ; 1355-7688
    DOI 10.1093/bjs/znae100
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Global academic response to COVID-19: Cross-sectional study

    Helliwell, Jack A / Bolton, William S / Burke, Joshua R / Tiernan, Jim P / Jayne, David G / Chapman, Stephen J

    medRxiv

    Abstract: Objective: To describe the global academic response to COVID-19 during its early stages. The responsiveness of investigators, editorial teams, and publishers was explored. Design: Cross-sectional bibliometric review of COVID-19 literature. A parallel ... ...

    Abstract Objective: To describe the global academic response to COVID-19 during its early stages. The responsiveness of investigators, editorial teams, and publishers was explored. Design: Cross-sectional bibliometric review of COVID-19 literature. A parallel search of Middle East Respiratory Syndrome (MERS) literature was performed for comparison of outcomes. Data sources: MEDLINE and EMBASE databases. The search for COVID-19 studies was performed between 1st November 2019 and 24th March 2020. The search for MERS studies was performed one year earlier between 1st November 2018 and 24th March 2019. Main outcome measures: Investigator-responsiveness was assessed by measuring the volume and type of published research. Editorial-responsiveness was assessed by measuring the time from manuscript submission to acceptance and the availability of original data to support the study results. Publisher-responsiveness was assessed by measuring the time from manuscript acceptance to first publication and the provision of open access. Results: In total, 398 of 2835 COVID-19 and 55 of 1513 MERS search results were eligible. Most COVID-19 studies were clinical reports (n=242; 60.8%) and the majority of these were case series (n=105; 43.4%) and single cases (n=65; 26.9%). The times from manuscript submission to acceptance (median: 5 days (IQR: 3-11) vs 71.5 days (38-106); P<0.001) and acceptance to publication (median: 5 days (IQR: 2-8) vs. 22.5 days (4-48.5-; P<0.001) were strikingly shorter for COVID-19. Almost all COVID-19 (n=396; 99.5%) and MERS (n=55; 100%) studies were available with open-access. Data sharing was infrequent, with original data available for 104 (26.1%) COVID-19 and 10 (18.2%) MERS studies (P=0.203). Conclusions: The early academic response to COVID-19 was characterised by investigators aiming to define the disease. These studies were made rapidly and openly available by editorial and publishing teams. Data sharing practises are an essential target for improvement as the pandemic progresses.
    Keywords covid19
    Language English
    Publishing date 2020-05-03
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2020.04.27.20081414
    Database COVID19

    Kategorien

To top